Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Changsha, China Clinical Trials

A listing of Changsha, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke

Currently, dual antiplatelet therapy with aspirin and clopidogrel (with loading doses) is widely used for patients with acute ischemic stroke. However, immediate, potent and reversible inhibition of platelet aggregation is not possible. Additionally, more than 5% patients have aspirin resistance and more than 15% patients have clopidogrel resistance. Therefore, an …

Phase

0.0 miles

Learn More »

A Study of the Relative Bioavailability of ASC41 in Healthy Subjects

The purpose of this study was to evaluate the tolerability, safety pharmacokinetics and pharmacodynamic (biomarkers) of ASC41 tables in a randomized, double-blind, placebo-controlled single- and multiple-dose phase I clinical trial in healthy subjects the study. The effects of ASC41 on LDL-C and other lipid parameters (TG, TC, HDL-C, etc.) will …

Phase

0.0 miles

Learn More »

Platelet Transfusion in Acute-on Chronic Liver Failure

Acute on-chronic liver failure (ACLF) is a severe liver disease with a 28-day mortality rate of up to 40%. When the patients get 3 or more organ failures, the 28-day mortality rate is up to 82.6%. Though the ACLF patients have high short-term mortality, and the only effective treatment method …

Phase N/A

0.0 miles

Learn More »

Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes

This is a single-blinded, 1:1 paralleled group cluster randomized controlled trial (RCT). The intervention will last for 24 weeks. The laboratory staff who test the HbA1c level, the outcome assessor who collects the blood glucose data, and the statisticians will be blinded to the treatment allocation. Sample size estimation: We …

Phase N/A

4.13 miles

Learn More »

SCOPE-Chinese Women Study

Cancer presents a major disease burden across the globe. The incidence and mortality of gynecologic cancers have increased significantly in China over the last two decades with breast and endometrial cancer as leading causes of death in women in China. Obesity, especially abdominal obesity, and unhealthy lifestyles are major risk …

Phase N/A

6.2 miles

Learn More »